prolactin-producing pituitary gland adenoma
prolactin-producing pituitary gland adenoma
Explore linked clinical trials. Standard reference: MONDO:00109116 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Investigation of Pituitary Tumors and Related Hypothalmic Disorders | ACTH-dependent Cushing syndrome, Bone Diseases, Developmental, Bone Diseases, Endocrine, Carcinogenesis, Combined Pituitary Hormone Deficiency, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pituitary Neoplasms, acromegaly, adenoma, bone disorder, brain disorder, central nervous system disorder, endocrine system disorder, epithelial neoplasm, hyperpituitarism, hypothalamic disorder, malignant endocrine neoplasm, musculoskeletal system disorder, neoplasm, nervous system disorder, pituitary gigantism, pituitary gland disorder, prolactin-producing pituitary gland adenoma | Recruiting | Not stated | 2026-09-22 | NCT00001595 | |
| Long Term Outcome Study in Patients With Pituitary Disorders | Bone Diseases, Endocrine, Neoplasms by Histologic Type, Neoplasms by Site, Pituitary Neoplasms, acromegaly, adenoma, bone disorder, brain disorder, central nervous system cancer, central nervous system disorder, endocrine system disorder, epithelial neoplasm, hyperpituitarism, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, musculoskeletal system disorder, neoplasm, nervous system disorder, pituitary gland disorder, prolactin-producing pituitary gland adenoma, supratentorial cancer | Active, not recruiting | Not stated | 2026-03-16 | NCT03665064 | |
| Safety and Potency of a High Cabergoline Dosage in Microprolactinomas | Neoplasms by Histologic Type, Neoplasms by Site, Pituitary Neoplasms, adenoma, brain disorder, central nervous system disorder, endocrine system disorder, epithelial neoplasm, hyperpituitarism, hyperprolactinemia, hypothalamic disorder, malignant endocrine neoplasm, neoplasm, nervous system disorder, pituitary gland disorder, prolactin-producing pituitary gland adenoma | Recruiting | Phase 3 | 2026-03-13 | NCT07463235 | |
| How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors | Macroprolactinoma, Neoplasms by Histologic Type, Neoplasms by Site, Pituitary Neoplasms, adenoma, brain disorder, central nervous system cancer, central nervous system disorder, endocrine system disorder, epithelial neoplasm, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, neoplasm, nervous system disorder, pituitary gland disorder, prolactin-producing pituitary gland adenoma, supratentorial cancer | Recruiting | Not stated | 2026-01-22 | NCT07268183 | |
| The PROMISE Survey | Neoplasms by Histologic Type, Neoplasms by Site, Pituitary Neoplasms, adenoma, brain disorder, central nervous system cancer, central nervous system disorder, endocrine system disorder, epithelial neoplasm, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, neoplasm, nervous system disorder, pituitary gland disorder, prolactin-producing pituitary gland adenoma, supratentorial cancer | Active, not recruiting | Not stated | 2026-01-08 | NCT06936813 | |
| Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment | Neoplasms by Histologic Type, Neoplasms by Site, Pituitary Neoplasms, adenoma, brain disorder, central nervous system disorder, endocrine system disorder, epithelial neoplasm, hyperpituitarism, hyperprolactinemia, hypothalamic disorder, malignant endocrine neoplasm, neoplasm, nervous system disorder, pituitary gland disorder, prolactin deficiency, isolated, prolactin-producing pituitary gland adenoma | Recruiting | Phase 4 | 2025-09-23 | NCT07045935 |